Dr. Kumar’s Take:
This is a systematic review and dose-response meta-analysis of prospective cohort studies, not a trial, so it describes associations rather than what happens when you change someone’s cholesterol. It found that higher total cholesterol and higher LDL-C are associated with increased cardiovascular mortality, and that higher HDL-C runs the other way. My clinical read: a hazard ratio tells you how the risk in one group compares to another, and a 27% relative increase in a fairly uncommon outcome is not the same thing as a 27% chance of dying. Cholesterol belongs in the risk picture, but it is one input among many, and I treat the patient in front of me rather than a single lipid number.
Brief Summary:
This meta-analysis compiled data from 14 independent reports, including 1,055,309 subjects and 9,457 events. Key findings include:
✔ Higher TC is associated with a 27% higher hazard of cardiovascular death (HR 1.27, 95% CI 1.19 to 1.36).
✔ Higher LDL-C is associated with a 21% higher hazard (HR 1.21, 95% CI 1.09 to 1.35).
✔ Higher HDL-C is inversely associated with cardiovascular death (HR 0.60, 95% CI 0.50 to 0.72).
✔ The authors observed a linear association between serum cholesterol (TC and HDL-C) levels and cardiovascular mortality.
Understanding Relative vs. Absolute Risk:
Many studies report relative risk (RR) or hazard ratio (HR), which shows how much more likely an event is in one group compared to another. Absolute risk (AR) is different: it tells you the actual probability that the event happens to a given person over a given stretch of time.
That distinction matters here because this meta-analysis is built entirely out of hazard ratios. The pooled figures of 1.27, 1.21 and 0.60 are comparisons between groups. They describe the direction and the strength of the association, and nothing about them tells you your personal odds. Two people can share the same hazard ratio and have very different underlying risk depending on age, blood pressure, diabetes, kidney function, smoking and family history.
So when a headline says cholesterol raises the risk of cardiac death by 27%, the honest reading is that it raises it by 27% of whatever your starting risk already was. For a 40-year-old with no other risk factors, that starting point is low. For a 70-year-old diabetic smoker, it is not.
Number Needed to Harm (NNH) and Number Needed to Treat (NNT):
Clinicians often translate risk into NNH and NNT, which measure how many people must be exposed to a risk factor, or treated, before one extra harmful or beneficial event occurs. Those numbers require the baseline event rate in each comparison group, and this analysis is reported as pooled hazard ratios. The findings you can take directly from it are these:
| Lipid Type | Pooled Hazard Ratio | 95% CI | Direction |
|---|---|---|---|
| Total Cholesterol | 1.27 | 1.19 to 1.36 | Higher risk of CVD death |
| LDL-C | 1.21 | 1.09 to 1.35 | Higher risk of CVD death |
| HDL-C | 0.60 | 0.50 to 0.72 | Lower risk of CVD death |
What Does This Mean?
✔ The associations for TC and LDL-C are consistent in direction, and the confidence intervals for all three sit clear of 1.0.
✔ HDL-C shows the strongest single association in the analysis, and it points toward protection.
✔ These are cohort data, so they show association, not proof that lowering a number lowers deaths.
Key Takeaways:
✔ Higher total cholesterol and higher LDL-C are associated with increased cardiovascular mortality across more than a million people.
✔ Higher HDL-C is inversely associated with cardiovascular mortality.
✔ The relationship for TC and HDL-C was linear across the range studied, which argues against a single magic threshold.
✔ Relative risk describes a comparison between groups. It is not a statement about your individual odds.
Related Studies and Research
Statins, LDL, and Low-Carb Diets – Examines the effects of statins on LDL cholesterol in the context of a low-carb diet, highlighting potential benefits and concerns.
LDL Cholesterol and Heart Health – Discusses the role of LDL cholesterol in cardiovascular disease and evaluates the latest research on its impact on heart health.
Frequently Asked Questions:
Should I be worried if my TC is high but my HDL is also high?
This analysis looked at each lipid separately and found opposite directions of association for total cholesterol and HDL-C. It did not test combinations, so I would not read a single reassuring HDL number as cancelling out the rest of the panel. Look at the whole picture with your physician.
Does lowering LDL always reduce heart disease risk?
This study cannot answer that. It pooled observational cohorts, which show that higher LDL-C travels with higher cardiovascular mortality. Demonstrating that lowering LDL reduces deaths requires interventional trials, which is a different body of evidence.
What are the best ways to reduce cardiovascular risk?
✔ Exercise regularly
✔ Follow a whole-food, low-inflammatory diet
✔ Avoid processed carbohydrates and excess sugars
✔ Manage stress and sleep quality
Conclusion:
The authors conclude that serum total cholesterol and LDL-C are associated with increased cardiovascular mortality, while HDL-C is inversely associated with it. That is a real signal drawn from a very large pooled population, and I take it seriously. I would still read it as one component of cardiovascular risk rather than the whole of it, because these are observational cohorts and because the strength of an association between groups says nothing about where any individual patient sits. Treating the full risk profile, not a single line on a lipid panel, is the more defensible approach.
